CTL, cytotoxic T cells
Cytotoxic T cells and viral hepatitis
7
Analysis of T cell responses in liver allograft recipients Evidence for deletion of donor specific cytotoxic T cells in the peripheral circulation
8
The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
11
Immunologic special forces: anti-pathogen cytotoxic T-lymphocyte immunotherapy following hematopoietic stem cell transplantation
10
Recognition of clonogenic leukemic cells, remission bone marrow and HLA identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen specific cytotoxic T lymphocytes
8
The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells
11
Fitness Costs and Diversity of the Cytotoxic T Lymphocyte (CTL) Response Determine the Rate of CTL Escape during Acute and Chronic Phases of HIV Infection
11
Effects of Cytotoxic T Lymphocytes (CTL) Directed against a Single Simian Immunodeficiency Virus (SIV) Gag CTL Epitope on the Course of SIVmac239 Infection
5
The reovirus nonstructural protein sigma1NS is recognized by murine cytotoxic T lymphocytes.
5
Progress in research on paclitaxel and tumor immunotherapy
11
Normal self proteins as targets for tumour specific cytotoxic T lymphocytes (CTL)
318
Enhanced presentation of MHC class Ia, Ib and class II restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
10
CD40 Ligand-Mediated Interactions Are Involved in the Generation of Memory CD8+ Cytotoxic T Lymphocytes (CTL) but Are Not Required for the Maintenance of CTL Memory following Virus Infection
10
Dynamics of a fractional order HBV infection model with capsids and CTL immune response
15
Virotheranostics, a double-barreled viral gun pointed toward cancer; ready to shoot?
17
The generation of cytotoxic T cell epitopes and their generation for cancer immunotherapy
184
Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP 1 and loss of expression of the immunodominant MART 1/Melan A antigen
10
Persistence of vesicular stomatitis virus in cloned interleukin-2-dependent natural killer cell lines.
9
MyD88 Expression Is Required for Efficient Cross-Presentation of Viral Antigens from Infected Cells
9
Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
8